The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) (Amendment) (No. 2) Regulations 2017
| Jurisdiction | UK Non-devolved |
| Citation | SI 2017/322 |
| Year | 2017 |
2017 No. 322
National Health Service, England
The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) (Amendment) (No. 2) Regulations 2017
Made 8th March 2017
Laid before Parliament 10th March 2017
Coming into force 1st April 2017
The Secretary of State makes these Regulations in exercise of the powers conferred by sections 6E(1) and (2) and 272(7) and (8) of the National Health Service Act 20061.
Citation and commencement
1. These Regulations may be cited as the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) (Amendment) (No. 2) Regulations 2017 and come into force on 1st April 2017.
Amendment of the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012
2.—(1) The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 20122are amended as follows.
(2) In regulation 20 (interpretation)—
(a)
(a) in the definition of “flat rate payment”, for “£156.25” substitute “£155.05”;
(b)
(b) in the definition of “high band payment”, for “£215.04” substitute “£213.32”.
David Mowat
Parliamentary Under-Secretary of State,
Department of Health
8th March 2017
EXPLANATORY NOTE
(This note is not part of the Regulations)
The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 ( S.I. 2012/2996) (“Standing Rules”) makes provision for, amongst other things, NHS Continuing Healthcare and NHS funded nursing care.
These Regulations amend regulation 20 of the Standing Rules. The amendments made by regulation 2(2) decrease the rates for NHS funded nursing care payable by the relevant body (the National Health Service Commissioning Board or a clinical commissioning group).
To continue reading
Request your trial